首页> 外文期刊>African Health Monitor >Laboratory capacity in 2012 for diagnosis of epidemic prone diseases in the context of Integrated Disease Surveillance and Response in the WHO African Region
【24h】

Laboratory capacity in 2012 for diagnosis of epidemic prone diseases in the context of Integrated Disease Surveillance and Response in the WHO African Region

机译:在2012年世卫组织非洲区域综合疾病监测和应对背景下诊断易流行病的实验室能力

获取原文
       

摘要

This paper provides the status of laboratory capacity for diagnosis of epidemic prone diseases in the context of Integrated Disease Surveillance and Response (IDSR) in 46 countries in the WHO African Region as of end of 2012 through self-assessment questionnaires. The findings from this assessment revealed that 98% (45/46) of the countries have the capacity for isolation, identification and antimicrobial susceptibility testing of common bacterial causes of enteric diseases and meningitis in the Region. Forty three countries performed standard enzyme-linked immunosorbent assay (ELISA) for confirming suspected cases of pathogens such as Morbillivirus responsible of measles through the detection of specific immunoglobulin M (IgM) and 30 countries had at least polymerase chain reaction (PCR) capacity for detection of influenza viruses. However, the number of countries with an appropriate department of virology providing comprehensive diagnostic services is still limited especially for dangerous viral pathogens requiring high-level containment facilities. The collection and analysis of critical information on the existing diagnostic capacity were used to propose key recommendations for strengthening the laboratory confirmation of outbreaks in line with the IDSR Strategy and the International Health Regulations (IHR, 2005). The proposed key actions were focused in the following areas: high-level advocacy for country ownership, human resource development, laboratory space and equipment, quality assurance and laboratory networking.
机译:本文通过自我评估问卷,提供了截至2012年底世卫组织非洲区域46个国家在综合疾病监测和应对(IDSR)背景下诊断易流行疾病的实验室能力的状况。评估的结果表明,该地区98%(45/46)的国家具有隔离,鉴定和分析肠道细菌常见疾病和脑膜炎的细菌敏感性的能力。 43个国家/地区进行了标准酶联免疫吸附测定(ELISA),以通过检测特异性免疫球蛋白M(IgM)来确认可疑病原体(例如麻疹病毒)的可疑病原体,还有30个国家至少具有聚合酶链反应(PCR)的检测能力流感病毒。但是,具有适当的病毒学部门提供全面诊断服务的国家数量仍然有限,特别是对于需要高水平收容设施的危险病毒病原体。利用有关现有诊断能力的关键信息的收集和分析,根据IDSR战略和《国际卫生条例》(IHR,2005年)提出了关键建议,以加强实验室对暴发的确认。拟议的关键行动集中在以下领域:倡导国家所有权,人力资源开发,实验室空间和设备,质量保证和实验室网络的高级别宣传。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号